International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical Conditions.

Aliu, Paul; Sarp, Séverine; Reichenbach, Ramona; Behr, Sigrid; Fitzsimmons, Paige; Shamlajee, Mansurahmad; Kola, Surya Prakash; Nunes Radimerski, Samantha; Scosyrev, Emil

Aliu, Paul; Sarp, Séverine; Reichenbach, Ramona; Behr, Sigrid; Fitzsimmons, Paige; Shamlajee, Mansurahmad; Kola, Surya Prakash; Nunes Radimerski, Samantha; Scosyrev, Emil.

Afiliação

Aliu P; Novartis Pharma AG, Basel, Switzerland.
Sarp S; Novartis Pharma AG, Basel, Switzerland.
Reichenbach R; Novartis Pharma AG, Basel, Switzerland.
Behr S; Novartis Pharma AG, Basel, Switzerland.
Fitzsimmons P; GE2P2 Global Foundation, Philadelphia, Pennsylvania.
Shamlajee M; Novartis Healthcare Pvt Ltd, Hyderabad, India.
Kola SP; Novartis Healthcare Pvt Ltd, Hyderabad, India.
Nunes Radimerski S; Novartis Pharma AG, Basel, Switzerland.
Scosyrev E; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

JAMA Health Forum ; 3(4): e220475, 2022 04.

Article em En | MEDLINE | ID: mdl-35977322

Assuntos

Ensaios de Uso Compassivo; Estudos de Coortes; Produto Interno Bruto; Humanos; Renda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ensaios de Uso Compassivo Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JAMA Health Forum Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google